Skip to main content
Top
Published in: Diabetologia 3/2010

01-03-2010 | Article

Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction

Authors: A. García-Patterson, I. Gich, S. B. Amini, P. M. Catalano, A. de Leiva, R. Corcoy

Published in: Diabetologia | Issue 3/2010

Login to get access

Abstract

Aims/hypothesis

The aim of the study was to analyse the insulin requirements of women with type 1 diabetes mellitus throughout pregnancy.

Methods

We have examined the weekly mean blood glucose (mmol/l), insulin requirements (U kg−1 day−1) and total insulin requirements (U/day) in 65 women with type 1 diabetes mellitus and tight metabolic control since before pregnancy (HbA1c ≤6.0%).

Results

Both insulin requirement and total insulin requirement displayed a peak in week 9, a nadir in week 16 and a second peak in week 37. For the change in insulin requirement (4.08% per week) and in total insulin requirement (5.19% per week), the sharpest slope was observed from week 16 to week 37. However, two changes of direction took place in the first 11 weeks and eight out of nine episodes of severe hypoglycaemia requiring treatment with glucagon or i.v. glucose took place in the first 16 weeks.

Conclusions/interpretation

Pregnant women with type 1 diabetes mellitus and tight metabolic control since before pregnancy displayed changes in insulin requirement and total insulin requirement with successive changes of direction. The sharpest slope was observed between 16 and 37 weeks, but insulin requirements were more unstable in the first 16 weeks. This information could help patients and physicians to react to changes in glycaemic pattern in a prompt and adequate way.
Appendix
Available only for authorised users
Literature
1.
go back to reference Preconception care of women with diabetes (1998) American Diabetes Association: Clinical Practice Recommendations. Diabetes Care 21 (Suppl 1):556–559 Preconception care of women with diabetes (1998) American Diabetes Association: Clinical Practice Recommendations. Diabetes Care 21 (Suppl 1):556–559
2.
go back to reference Guerin A, Nisenbaum R, Ray JG (2007) Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 30:1920–1925CrossRefPubMed Guerin A, Nisenbaum R, Ray JG (2007) Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 30:1920–1925CrossRefPubMed
3.
go back to reference Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ (2006) Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth 6:30CrossRefPubMed Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ (2006) Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth 6:30CrossRefPubMed
4.
go back to reference Jensen DM, Korsholm L, Ovesen P et al (2009) Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 32:1046–1048CrossRefPubMed Jensen DM, Korsholm L, Ovesen P et al (2009) Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 32:1046–1048CrossRefPubMed
5.
go back to reference Hiilesmaa V, Suhonen L, Teramo K (2000) Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 43:1534–1539CrossRefPubMed Hiilesmaa V, Suhonen L, Teramo K (2000) Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia 43:1534–1539CrossRefPubMed
6.
go back to reference Koukkou E, Young P, Lowy C (1997) The effect of maternal glycemic control on fetal growth in diabetic pregnancies. Am J Perinatol 14:547–552CrossRefPubMed Koukkou E, Young P, Lowy C (1997) The effect of maternal glycemic control on fetal growth in diabetic pregnancies. Am J Perinatol 14:547–552CrossRefPubMed
7.
go back to reference Banerjee S, Ghosh US, Banerjee D (2004) Effect of tight glycaemic control on fetal complications in diabetic pregnancies. J Assoc Phys India 52:109–113 Banerjee S, Ghosh US, Banerjee D (2004) Effect of tight glycaemic control on fetal complications in diabetic pregnancies. J Assoc Phys India 52:109–113
8.
go back to reference Ylinen K (1987) High maternal levels of hemoglobin A1c associated with delayed fetal lung maturation in insulin-dependent diabetic pregnancies. Acta Obstet Gynecol Scand 66:263–266CrossRefPubMed Ylinen K (1987) High maternal levels of hemoglobin A1c associated with delayed fetal lung maturation in insulin-dependent diabetic pregnancies. Acta Obstet Gynecol Scand 66:263–266CrossRefPubMed
9.
go back to reference Steel JM, Johnstone FD, Hume R, Mao J-H (1994) Insulin requirements during pregnancy in women with type I diabetes. Obstet Gynecol 83:253–258PubMed Steel JM, Johnstone FD, Hume R, Mao J-H (1994) Insulin requirements during pregnancy in women with type I diabetes. Obstet Gynecol 83:253–258PubMed
10.
go back to reference Kimmerle R, Heinemann L, Delecki A, Berger M (1992) Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 15:1034–1037CrossRefPubMed Kimmerle R, Heinemann L, Delecki A, Berger M (1992) Severe hypoglycemia incidence and predisposing factors in 85 pregnancies of type I diabetic women. Diabetes Care 15:1034–1037CrossRefPubMed
11.
go back to reference Coustan DR, Reece EA, Sherwin RS et al (1986) A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA 255:631–636CrossRefPubMed Coustan DR, Reece EA, Sherwin RS et al (1986) A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA 255:631–636CrossRefPubMed
12.
go back to reference Langer O, Anyaegbunam A, Brustman L, Guidetti D, Levy J, Mazze R (1988) Pregestational diabetes: Insulin requirements throughout pregnancy. Am J Obstet Gynecol 159:616–621PubMed Langer O, Anyaegbunam A, Brustman L, Guidetti D, Levy J, Mazze R (1988) Pregestational diabetes: Insulin requirements throughout pregnancy. Am J Obstet Gynecol 159:616–621PubMed
13.
go back to reference Evers IM, de Valk HW, Visser GH (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328:915CrossRefPubMed Evers IM, de Valk HW, Visser GH (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328:915CrossRefPubMed
14.
go back to reference Harris JA, Benedict FG (1919) A biometric study of basal metabolism in man. Publication no. 279. Carnegie Institution of Washington, Washington Harris JA, Benedict FG (1919) A biometric study of basal metabolism in man. Publication no. 279. Carnegie Institution of Washington, Washington
15.
go back to reference Durnin JG (1991) Energy requirements of pregnancy. Diabetes 40(Suppl 2):152–156PubMed Durnin JG (1991) Energy requirements of pregnancy. Diabetes 40(Suppl 2):152–156PubMed
16.
go back to reference Jovanovic L, Knopp RH, Brown Z, National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study Group et al (2001) Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care 24:1130–1136CrossRefPubMed Jovanovic L, Knopp RH, Brown Z, National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study Group et al (2001) Declining insulin requirement in the late first trimester of diabetic pregnancy. Diabetes Care 24:1130–1136CrossRefPubMed
17.
go back to reference McManus RM, Ryan EA (1992) Insulin requirements in insulin-dependent and insulin-requiring GDM women during final month of pregnancy. Diabetes Care 15:1323–1327CrossRefPubMed McManus RM, Ryan EA (1992) Insulin requirements in insulin-dependent and insulin-requiring GDM women during final month of pregnancy. Diabetes Care 15:1323–1327CrossRefPubMed
18.
go back to reference Fuglsang J, Lauszus F, Flyvbjerg A, Ovesen P (2003) Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes. J Clin Endocrinol Metab 88:4355–4361CrossRef Fuglsang J, Lauszus F, Flyvbjerg A, Ovesen P (2003) Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes. J Clin Endocrinol Metab 88:4355–4361CrossRef
19.
go back to reference Pedersen J (1981) Influencia del embarazo en la mujer diabética. In: Pedersen J (ed) La gestante diabética y su recién nacido. Salvat Editores, Barcelona, pp 77–87 Pedersen J (1981) Influencia del embarazo en la mujer diabética. In: Pedersen J (ed) La gestante diabética y su recién nacido. Salvat Editores, Barcelona, pp 77–87
20.
go back to reference Kirwan JP, Hauguel-De Mouzon S, Lepercq J et al (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207–2213CrossRefPubMed Kirwan JP, Hauguel-De Mouzon S, Lepercq J et al (2002) TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51:2207–2213CrossRefPubMed
21.
go back to reference Nielsen LR, Rehfeld JF, Pedersen-Bjergaard U, Damm P, Mathiesen ER (2009) Pregnancy-induced rise in serum C-peptide concentrations in women with Type 1 diabetes. Diabetes Care 32:1052–1057CrossRefPubMed Nielsen LR, Rehfeld JF, Pedersen-Bjergaard U, Damm P, Mathiesen ER (2009) Pregnancy-induced rise in serum C-peptide concentrations in women with Type 1 diabetes. Diabetes Care 32:1052–1057CrossRefPubMed
22.
go back to reference Gadsby R, Barnie-Adshead AM, Jagger C (1993) A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract 43:245–248PubMed Gadsby R, Barnie-Adshead AM, Jagger C (1993) A prospective study of nausea and vomiting during pregnancy. Br J Gen Pract 43:245–248PubMed
23.
go back to reference Catalano PM, Roman-Drago NM, Amini SB, Sims EA (1998) Longitudinal changes in body composition and energy balance in lean women with normal and abnormal glucose tolerance during pregnancy. Am J Obstet Gynecol 179:156–165CrossRefPubMed Catalano PM, Roman-Drago NM, Amini SB, Sims EA (1998) Longitudinal changes in body composition and energy balance in lean women with normal and abnormal glucose tolerance during pregnancy. Am J Obstet Gynecol 179:156–165CrossRefPubMed
24.
go back to reference Okereke NC, Huston-Presley L, Amini SB, Kalhan S, Catalano PM (2004) Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Am J Physiol Endocrinol Metab. 287:E472–E479CrossRefPubMed Okereke NC, Huston-Presley L, Amini SB, Kalhan S, Catalano PM (2004) Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Am J Physiol Endocrinol Metab. 287:E472–E479CrossRefPubMed
25.
go back to reference Mishell DR Jr, Thorneycroft IH, Nagata Y, Murata T, Nakamura RM (1973) Serum gonadotropin and steroid patterns in early human gestation. Am J Obstet Gynecol 117:631–642PubMed Mishell DR Jr, Thorneycroft IH, Nagata Y, Murata T, Nakamura RM (1973) Serum gonadotropin and steroid patterns in early human gestation. Am J Obstet Gynecol 117:631–642PubMed
26.
go back to reference Glinoer D, de Nayer P, Bourdoux P et al (1990) Regulation of maternal thyroid function during pregnancy. J Clin Endocrinol Metab 71:276–287CrossRefPubMed Glinoer D, de Nayer P, Bourdoux P et al (1990) Regulation of maternal thyroid function during pregnancy. J Clin Endocrinol Metab 71:276–287CrossRefPubMed
27.
go back to reference Ryan EA, Enns L (1988) Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 67:341–347CrossRefPubMed Ryan EA, Enns L (1988) Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 67:341–347CrossRefPubMed
28.
go back to reference Kennedy RL, Darne J, Gryffiths H, Price A, Davies R, Cohn M (1990) Thyroid-stimulatory effects of human chorionic gonadotrophin in early pregnancy. Horm Res 33:177–183CrossRefPubMed Kennedy RL, Darne J, Gryffiths H, Price A, Davies R, Cohn M (1990) Thyroid-stimulatory effects of human chorionic gonadotrophin in early pregnancy. Horm Res 33:177–183CrossRefPubMed
29.
go back to reference Ohguni S, Notsu K, Kato Y (1995) Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves’ disease. Intern Med 34:339–341CrossRefPubMed Ohguni S, Notsu K, Kato Y (1995) Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves’ disease. Intern Med 34:339–341CrossRefPubMed
Metadata
Title
Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction
Authors
A. García-Patterson
I. Gich
S. B. Amini
P. M. Catalano
A. de Leiva
R. Corcoy
Publication date
01-03-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 3/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1633-z

Other articles of this Issue 3/2010

Diabetologia 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.